CXCL10 and periodontal disorder: Conversely, although IP-10 levels were reduced in diabetic patients across all stages of periodontal disease (F (1, 159) = 21.58 and p < 0.0001), this reduction reached statistical significance only in healthy and gingivitis individuals (p = 0.0005 and p = 0.008, respectively; Figure 2M).